News

Search here results

• Nicholas McGranahan selected as EMBO Young Investigator 2020 | UCL Cancer Institute - UCL – University College London
• COVID-19: Fall in cancer treatment rose following ‘rapid’ NHS guidance | UCL Cancer Institute - UCL – University College London
• New immunotherapy shows promise against rare childhood cancer | UCL Cancer Institute - UCL – University College London
• Interview: Developing a new immunotherapy to gain control of cancer | UCL Cancer Institute - UCL – University College London
• War in the Blood wins Best Science Documentary prize | UCL Cancer Institute - UCL – University College London
• Next-generation immunotherapy entering early phase clinical trials | UCL Cancer Institute - UCL – University College London
• Monitoring mitochondrial activitity to identify 'young' stem cells | UCL Cancer Institute - UCL – University College London
• Towards better diagnosis of peripheral nerve tumours | UCL Cancer Institute - UCL – University College London
• Insight into immune cell activation could help identify Covid-19 patients most at risk of pneumonia | UCL Cancer Institute - UCL – University College London
• Targeting the TBXT gene to combat chordoma | UCL Cancer Institute - UCL – University College London